Neurostimulation for Cognitive Enhancement in Alzheimer's Disease

NAActive, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 25, 2021

Primary Completion Date

October 31, 2025

Study Completion Date

January 31, 2026

Conditions
Alzheimer DiseaseDementia
Interventions
DEVICE

tDCS device model Soterix mini-CT (Soterix Medical Inc., New York, NY) programed to deliver active tDCS.

At-home remotely supervised tDCS delivered over the dorsolateral prefrontal cortex with the anode on the left, cathode on the right, at an intensity of 2 mA, delivered for 30 minutes five times per week (Monday-Friday) for 26 weeks (6 months).

DEVICE

tDCS device model Soterix mini-CT (Soterix Medical Inc., New York, NY) programed to deliver sham tDCS.

Sham treatment will consist of the current ramped up to 2mA over 30 seconds, ramped down over 30 seconds and stay at 0 current for the remaining time of the 30-minute application period five times per week (Monday-Friday) for 26 weeks (6 months).

Trial Locations (1)

10461

Albert Einstein College of Medicine, The Bronx

All Listed Sponsors
collaborator

MJHS Institute for Innovation in Palliative Care

OTHER

collaborator

Stony Brook University

OTHER

lead

Albert Einstein College of Medicine

OTHER